LexisNexis® Legal News Podcast for October 7, 2008

Nevada’s high court finds later owners of allegedly defective homes may sue the builder, and, Cephalon will pay $450 million for off-label marketing of 3 drugs. Hear these and other stories from LexisNexis® Mealey’s™ Emerging Drugs and Devices, Pollution Liability and Construction Defects litigation Reports. Copyright© 2008 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, go to www.lexisnexis.com/mealeys.

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

No related posts.